Sangamo Therapeutics (SGMOQ) Net Margin Growth (3y) (2013 - 2025)
Powered by 
Analysis
Sangamo Therapeutics (SGMOQ) Net Margin Growth (3y) (2013 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Krystal Biotech | 10.28 Bn | 9.43 Bn | 112.79 Mn | - |
| 2 | CRISPR Therapeutics AG | 5.20 Bn | 5.20 Bn | - | -78,467.00 |
| 3 | Iovance Biotherapeutics | 3.76 Bn | 3.46 Bn | 55.72 Mn | 4.47 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn | 29,163.00 |
| 5 | uniQure | 3.07 Bn | 3.07 Bn | 5.49 Mn | 143,941.00 |
| 6 | Beam Therapeutics | 2.67 Bn | 2.67 Bn | - | -2.46 Mn |
| 7 | Precigen | 2.43 Bn | 2.43 Bn | 52.17 Mn | 118,642.00 |
| 8 | Sarepta Therapeutics | 2.34 Bn | 1.54 Bn | 251.87 Mn | 795.00 |
| 9 | Vericel | 2.00 Bn | 1.83 Bn | 56.40 Mn | 1,380.00 |
| 10 | Sangamo Therapeutics | 43.15 Mn | 22.20 Mn | - | -7,224.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -7,224.00 |
| Sep 30, 2025 | -581,116.00 |
| Jun 30, 2025 | 3,778.00 |
| Mar 31, 2025 | -31,941.00 |
| Dec 31, 2024 | -22,605.00 |
| Sep 30, 2024 | 18,595.00 |
| Jun 30, 2024 | -997,908.00 |
| Mar 31, 2024 | -1.00 Mn |
| Dec 31, 2023 | -279,509.00 |
| Sep 30, 2023 | -110,574.00 |
| Jun 30, 2023 | -150,842.00 |
| Mar 31, 2023 | 34,203.00 |
| Sep 30, 2022 | 913.00 |
| Jun 30, 2022 | 13,627.00 |
| Mar 31, 2022 | 36,697.00 |
| Dec 31, 2021 | -6,227.00 |
| Sep 30, 2021 | -11,245.00 |
| Jun 30, 2021 | -9,154.00 |
| Mar 31, 2021 | -787.00 |
| Dec 31, 2020 | -5,755.00 |